SHTG advice statements

SHTG advice statements

SHTG Advice Statements outline in as consistent a manner as possible the view of the SHTG on the clinical effectiveness, safety and cost effectiveness evidence for the technology in question in the context of NHSScotland.

The status of SHTG Advice Statements for NHSScotland is ‘required to consider’. They are intended to assist NHS planners and decision makers when determining the place of health technologies for local use. It is acknowledged that the evidence constitutes only one of the sources needed for decision making and planning in NHSScotland. SHTG advice does not override the individual responsibility of health professionals to make decisions in the exercise of the clinical judgement in the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.

Share this content

Published Date: default

Evidence

Latest SHTG publications

  • What is the evidence for the clinical and cost effectiveness of single room only wards in hospitals compared with non-single room only wards?
    Evidence note

    Advice Statement
  • What is the published evidence on the accuracy, turnaround time and cost/cost effectiveness of tests to identify carbapenemase-producing Enterobacteriaceae (CPE) in hospital screening samples obtained from patients identified as at risk of CPE colonisation during clinical risk assessment?
    Evidence note
    Advcie Statement
  • What is the clinical effectiveness, safety and cost effectiveness of endovascular therapy using mechanical thrombectomy devices for patients with acute ischaemic stroke?
    Evidence note
    Advice Statement
  • What is the clinical effectiveness, cost effectiveness and safety of home health monitoring compared with usual care for patients with moderate to severe chronic obstructive pulmonary disease?
    Evidence note
    Advice Statement